Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
about
Modafinil as a catecholaminergic agent: empirical evidence and unanswered questionsR-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuseThe novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization propertiesThe atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitorsModafinil-induced conditioned place preference via dopaminergic system in mice.Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendationsPharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.Rodent models of treatment-resistant depression.Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction.A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorderPreclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with ModafinilEffects of modafinil and R-modafinil on brain stimulation reward thresholds: implications for their use in the treatment of psychostimulant dependence.R-modafinil attenuates nicotine-taking and nicotine-seeking behavior in alcohol-preferring ratsTriple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited.Challenges in the development of therapeutics for narcolepsy.Discriminative Stimulus Properties of S(-)-Nicotine: "A Drug for All Seasons".Oral modafinil facilitates intracranial self-stimulation in rats: comparison with methylphenidate.The unique psychostimulant profile of (±)-modafinil: investigation of behavioral and neurochemical effects in mice.Assessment of substance abuse liability in rodents: self-administration, drug discrimination, and locomotor sensitization.The Combination of Scopolamine and Psychostimulants for the Prevention of Severe Motion Sickness.Addictive potential of modafinil and cross-sensitization with cocaine: a pre-clinical study.Duration of activity and mode of action of modafinil: Studies on sleep and wakefulness in humans.Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain.Modafinil improves performance in the multiple T-Maze and modifies GluR1, GluR2, D2 and NR1 receptor complex levels in the C57BL/6J mouse.Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.
P2860
Q21129426-3B036B48-BC92-4795-8E3A-257D5490B290Q24621917-DD220D69-0F68-470A-8A74-02BF4BCFC59FQ24633511-F5017DFA-DE46-4551-BD4E-DA06997E9C17Q28477546-088CBA98-49B6-4CC2-8846-3195EF34C9C8Q34154970-84D260E0-AC4F-4DA4-9E20-BC723DE145F1Q34225896-24CCD0BF-4AAD-47FF-92C4-DF410BB5F1A5Q34253787-DE1D05E5-35F7-4361-8650-285689897D3FQ34494307-B6DC4803-8B7A-4C9F-A62D-E9C526048D08Q35580361-8EF80D35-17D8-4F6A-A1D4-74F7442300FAQ35673212-DC129D27-ED29-4FD4-938F-F2D740B0DB77Q35781823-A366FE95-B7E3-4E6D-AD69-4852CAE31C8BQ35927738-B0390BA9-0D1E-4B13-9BE2-64C87D4DF59AQ36630601-A6EB8E76-35F8-43C4-95AB-30C0DF6655C4Q36929453-78E443B6-B76A-4E29-B6AE-2D22E67335A6Q36977149-734087B1-1373-4748-A7C7-2847EA4D329AQ37024852-26C17BE0-2320-4FE1-B9CF-6C81B201A993Q37891098-1A6E55CC-D572-449D-84F0-FA7F1E3E3E55Q38684472-B2A58A3D-9A63-41D4-B383-5BEF6A515005Q38732951-D6373BC0-46D8-4AA8-96E9-B86D655E946DQ45051527-8C9E4AF9-975A-4E3A-BF87-A8482E91A29DQ47103759-C927C6DD-59AA-4E85-875E-A06CA4F20F22Q47188459-35364F0B-AE94-4F43-A218-83D77083E86EQ47432721-E19E0457-690F-4283-98C0-0E7D04CC474AQ48121495-5B26DE18-F882-4625-A477-329B2805FB5BQ48139080-5DC74DA6-A926-413F-A138-440099490F29Q48250330-325DABDA-3989-44B3-B8DE-0B9F8D192C7DQ48499494-D2A86F7E-4C68-4F1C-BE33-2F5F83779BADQ52638749-90AE69A2-073F-4F56-A93A-E4589BB0F53B
P2860
Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Psychostimulant-like discrimin ...... ng agent modafinil in rodents.
@en
type
label
Psychostimulant-like discrimin ...... ng agent modafinil in rodents.
@en
prefLabel
Psychostimulant-like discrimin ...... ng agent modafinil in rodents.
@en
P2093
P2860
P1476
Psychostimulant-like discrimin ...... ng agent modafinil in rodents.
@en
P2093
Afshin Ghavami
Allison Fedolak
Barbara Caldarone
Berend Olivier
Neil E Paterson
Taleen Hanania
P2860
P304
P356
10.1016/J.PBB.2010.03.006
P407
P577
2010-03-25T00:00:00Z